跳至內容

O-1238

維基百科,自由的百科全書
O-1238
識別資訊
  • (6aR)-3-[(Z)-6-Azidohex-2-enyl]-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
CAS號229030-01-7  checkY
PubChem CID
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
化學資訊
化學式C22H29N3O2
摩爾質量367.49 g·mol−1
3D模型(JSmol英語JSmol
  • CC3=CCC2C(C)(C)Oc(c1C2C3)cc(cc1O)CC=CCCCN=N=N
  • InChI=1S/C22H29N3O2/c1-15-9-10-18-17(12-15)21-19(26)13-16(14-20(21)27-22(18,2)3)8-6-4-5-7-11-24-25-23/h4,6,9,13-14,17-18,26H,5,7-8,10-12H2,1-3H3/b6-4-/t17?,18-/m1/s1
  • Key:WCIOISWISHFTFW-UWFURQARSA-N

O-1238cis-3-(6-疊氮基-2-己烯基)-Δ8-THC)是一種含氮有機化合物,化學式C
22
H
29
N
3
O
2
,帶有疊氮基官能團,屬於人工合成的大麻素[1]。它可以6-(3,5-二甲氧基苯基)-4-己炔-1-醇為原料反應製得。[2]

參考文獻

[編輯]
  1. ^ Griffin G, Wray EJ, Martin BR, Abood ME. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British Journal of Pharmacology. October 1999, 128 (3): 684–8. PMC 1571656可免費查閱. PMID 10516649. doi:10.1038/sj.bjp.0702806. 
  2. ^ Peter J. Crocker; Bijali Saha; William J. Ryan; Jenny L. Wiley; Billy R. Martin; Ruth A. Ross; Roger G. Pertwee; Raj K. Razdan (1999). Development of agonists, partial agonists and antagonists in the Δ8-Tetrahydrocannabinol series. Tetrahedron, 55(49), 13907–13926. doi:10.1016/s0040-4020(99)00849-2.